Biohaven Pharmaceutical Holding Co. Ltd.
www.biohavenpharma.com
Latest From Biohaven Pharmaceutical Holding Co. Ltd.
Biopharma Quarterly Dealmaking Statistics, Q2 2019
Biopharma companies raised $12.4bn in Q2, largely from follow-on public offerings. In the latest mega-merger of the year, AbbVie spent $63bn on Allergan and its established portfolio. Many of the higher-valued alliances focused on the area of protein degradation.
Keeping Track: US FDA Clears Two More Biosimilars, First Non-Injectable Glucagon
The latest drug development news and highlights from our US FDA Performance Tracker.
GW Pharma’s Cannabidiol For Seizures One Step Closer To European Approval
The CHMP has issued a positive opinion for Epidyolex for two rare conditions. The cannabidiol product was approved in the US in 2018.
Kleo Brings Small-Molecule Approach To IO With Three Technological Applications
Emerging Company Profile: Using IP licensed from Yale, Kleo is betting it can complement or replace existing immuno-oncology drugs, specifically Darzalex. In partnership with PeptiDream, it just unveiled its first candidate for clinical development.
Company Information
- Industry
-
Biotechnology
- Large Molecule
- Pharmaceuticals
- Therapeutic Areas
- Neurology, Nervous System
- Alias(es)
- Biohaven Pharmaceuticals
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Biohaven Pharmaceutical Holding Co. Ltd.
- Senior Management
-
Vlad Coric, MD, CEO
Jim Engelhart, CFO
Robert Berman, MD, CMO
John Tilton, Chief Commercial Officer
Charlie Conway, PhD, CSO
Elyse Stock, MD, Chief, Portfolio Strategy & Dev.
Donnie McGrath, MD, Chief, Corp. Strategy & Bus. Dev.
Kim Gentile, VP, Operations - Contact Info
-
Biohaven Pharmaceutical Holding Co. Ltd.
Phone: (203) 404-0410
234 Church St.
New Haven, CT 06510
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice